Routine use of HPV vaccine in males provides direct benefits to men and their sexual partners, will increase overall immunization rates among both males and females, and may be cost-effective; SAHM strongly recommends routine use of HPV vaccination in males as well as in females. We urge clinicians and insurance organizations to consider the benefit of routine vaccination for all age-appropriate patients, regardless of gender, in an effort to support the primary prevention of disease among adolescents and adults.
Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getti... Read Post
On May 28, 2010, the Advisory Committee on Immunization Practices (ACIP) published its guidance for use of the quadrivalent HPV vaccine in males. While noting that the vaccine was approved by the FDA for use in males ages 9 through ... Read Post